Eagle Bay Advisors’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-428
Closed -$79K 299
2024
Q4
$79K Sell
428
-105
-20% -$20.2K 0.05% 255
2024
Q3
$105K Sell
533
-75
-12% -$15.6K 0.04% 274
2024
Q2
$126K Sell
608
-39
-6% -$8.84K 0.08% 180
2024
Q1
$175K Sell
647
-158
-20% -$37.7K 0.11% 140
2023
Q4
$190K Sell
805
-40
-5% -$7.87K 0.12% 141
2023
Q3
$166K Buy
845
+179
+27% +$36.7K 0.08% 165
2023
Q2
$140K Sell
666
-114
-15% -$22.7K 0.08% 159
2023
Q1
$157K Sell
780
-55
-7% -$12.5K 0.09% 154
2022
Q4
$182K Buy
835
+550
+193% +$120K 0.1% 145
2022
Q3
$57K Sell
285
-348
-55% -$75.1K 0.04% 315
2022
Q2
$135K Buy
633
+478
+308% +$117K 0.08% 163
2022
Q1
$44K Sell
155
-158
-50% -$48.7K 0.04% 151
2021
Q4
$118K Buy
313
+48
+18% +$18.6K 0.08% 154
2021
Q3
$108K Sell
265
-82
-24% -$34.1K 0.06% 221
2021
Q2
$130K Buy
+347
New +$116K 0.1% 123

Other funds holding CRL